Switzerland's Sandoz files antitrust lawsuit against Amgen in US
14/04/2025 06:08
April 14 (Reuters) - Swiss generic drug manufacturer Sandoz SDZ.S said on Monday it had filed an antitrust lawsuit in the U.S. against Amgen AMGN.O for entrenching the dominant market position of its blockbuster medicine, Enbrel (etanercept). (Reporting by Abinaya Vijayaraghavan; Editing by Rashmi Aich) ((Abinaya.V@thomsonreuters.com;))
Recent news on Sandoz AG
See all newsPfizer dismissed from US states' drug price-fixing lawsuit (updated)
Pfizer dismissed from US states' drug price-fixing lawsuit
Factbox: Major investment pledges at Choose France summit
Press Digest: Financial Times - June 1
Media: Sandoz warns cheap Chinese imports threaten Europe’s antibiotic supply- FT